Old Mission Capital’s Molecular Partners MOLN Stock Holding History

Old Mission Capital’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,365	Closed	-$74.9K	–	1642
2024 Q2	$74.9K	Buy	+10,365	New	+$48.5K	﹤0.01%	1134
2021 Q3	–	Sell	-14,781	Closed	-$303K	–	1168
2021 Q2	$303K	Buy	+14,781	New	+$293K	0.01%	774

Other funds holding MOLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Old Mission Capital's MOLN Position: Q3 2024 in Review

Old Mission Capital sold out of Molecular Partners (MOLN) in Q3 2024, closing a stake of 10,365 shares — an estimated $74.9K sold.

Old Mission Capital first reported a position in MOLN in Q2 2021 and held it in 2 quarters. The position peaked at $303K in Q2 2021. 5 funds tracked by Wall St. Rank hold MOLN as of Q3 2024.

Old Mission Capital reported no remaining Molecular Partners position as of Q3 2024 after selling out during the quarter.
Old Mission Capital sold 10,365 Molecular Partners shares in Q3 2024, an estimated $74.9K.
Old Mission Capital first reported a position in Molecular Partners in Q2 2021 and held it in 2 quarters.
Old Mission Capital's Molecular Partners position peaked at $303K in Q2 2021.
5 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2024.

Based on Old Mission Capital's 13F filing for Q3 2024, filed 14 Nov 2024.